Armotraz
Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.
- Categories
- Women's Health · Oncology Support · Pct & Men's Fitness
- Active ingredient
- Anastrozole
- Supply
- Rx
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 1mg
Armotraz details
- Conditions
- Breast Cancer · Adjuvant Therapy
- Alternative names
- Arimidex
- Therapeutic class
- Aromatase Inhibitor
- Pharmacological class
- Nonsteroidal Aromatase Inhibitor
- Known off-label uses
- gynaecomastia
- Contraindications
- hypersensitivity to anastrozole; pregnancy; breastfeeding; premenopausal women
- Minor side effects
- hot flushes; asthenia; arthralgia; nausea; rash
- Moderate side effects
- bone fractures; osteoporosis; depression; elevated liver enzymes
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- AstraZeneca
- Onset Time
- N/A
- Duration
- N/A
- Storage instructions
- Store below 30°C.
- Drug interactions
- tamoxifen; oestrogen-containing therapies
- Age restrictions
- Adults only.
- Pregnancy and breastfeeding
- Pregnancy: Contraindicated. Breastfeeding: Contraindicated.
Precautions and warnings
bone density monitoring recommended; may cause fatigue; regular cholesterol assessments needed
Serious side effects
severe skin reactions, requires immediate medical attention; myocardial infarction, requires immediate medical attention
Patient summary
Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.
Mechanism of action
Anastrozole acts as a potent, highly selective non-steroidal aromatase inhibitor, preventing the conversion of androgens to oestrogens in peripheral tissues, which suppresses oestrogen levels.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Armotraz
Armotraz provides anastrozole, a medication widely utilised for breast cancer and adjuvant therapy. The same active ingredient is also sold under the brand name Arimidex. These tablets are available in the 1mg strength, offering a standard option for patients requiring targeted hormonal management.
Armotraz availability in Asia
Armotraz is registered across 13 markets, including Singapore, Hong Kong and Thailand, with further availability in Malaysia, the Philippines and Indonesia. Generic anastrozole, often manufactured in India, provides a cost-effective alternative to branded medicine for many patients across the region. Such treatments are best used under a doctor’s care, ensuring consistent monitoring during long-term hormonal therapy for those living away from home or in locations with limited access to appropriate medical care.